Frontlight ResearchEarly access
CompletedNo phase
The SPOT-HPV Study
Key facts
- Who runs it
- Dana-Farber Cancer Institute
- Where
- Boston, United StatesSee the 2 sites
- Trial code
- Status
- Completed
- People taking part
- 360 people enrolled
- Started
- 30 Nov 2022
- Ended
- 1 Jan 2026
- Type of study
- Observational, 2 groups
- Treatments tested
- Salivary TTMV-HPV DNA Test
- Blood TTMV-HPV DNA Test
- Record updated
- 21 January 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- Age 18+ years
- Able to provide informed consent
- Either one of the following:; Control cohort: Male individuals WITHOUT head and neck tumors that are, or may be, HPV-positive; Case cohort: Any individual WITH incident, untreated HPV-positive oropharynx squamous cell carcinoma
Who cannot take part
- Unable to provide informed consent
- Head and neck tumors of non-oropharynx subsites that are or may be HPV-positive, including oral cavity, sinonasal, laryngeal, hypopharyngeal, or nasopharyngeal squamous cell carcinomas
Where in United States
- Brigham & Woman's HospitalBoston, United States
- Dana-Farber Cancer InstituteBoston, United States
About the trial
What the trial wants to find out
The purpose of this research is to evaluate a new test for oral HPV DNA in saliva ('oral rinse test').
The 2 groups in the trial
- Control Cohort: Adult Male Without HPV-positive throat cancer
Participants will receive 1x Salivary TTMV-HPV DNA Test. If test is negative there will not be follow up, if test is positive participants will have repeat Salivary TTMV-HPV DNA Test, a blood test and head and neck exam.
Treatment: Salivary TTMV-HPV DNA Test and Blood TTMV-HPV DNA Test
- Case Cohort: Any Adult With HPV-positive throat cancer
Participants will receive 1x Salivary and Blood TTMV-HPV DNA Test(s).
Treatment: Salivary TTMV-HPV DNA Test
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Characterizing the Specificity and Sensitivity of Oral TTMV-HPV DNA Testing: The SPOT-HPV Study
- Record updated
- 21 January 2026